Global Markets Direct's, 'Intestinal Cancer - Pipeline Review, H2 2012',
provides an overview of the indication's therapeutic pipeline. This
report provides information on the therapeutic development for
Intestinal Cancer, complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Intestinal Cancer.
Intestinal Cancer - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets
Direct's team.